Home > Urology > EAU 2019 > Andrology > Testosterone replacement therapy: Safe and maybe even protective

Testosterone replacement therapy: Safe and maybe even protective

Presented By
Prof. Thomas Ahlering, Dr Maxwell Towe, Ribeiro Morgado
EAU 2019
There was an exciting plenary debate on the safety of testosterone therapy after curative treatment of prostate cancer between Dr John Mulhall (Memorial Sloan Kettering Cancer Center, USA) and Prof. Bertrand Tombal (Catholic University Leuven, Belgium). The final conclusion from both speakers was that testosterone therapy is probably safe to give to certain patients with confirmed signs and symptoms of hypogonadism, even if they have been treated for prostate cancer with curative intent. In the largest such study so far undertaken, Prof. Thomas Ahlering (University of California at Irvine, USA) presented a study where patients were selected for testosterone replacement after primary treatment of prostate cancer with robotic radical prostatectomy, in hopes of improving recovery of sexual function. You can watch Prof. Ahlering perform this surgery, streamed live on 29 January 2019 [online

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on